Retaglutide and tirzepatide are newer GLP-1 receptor agonists gaining popularity as effective treatment options for type 2 diabetes. These medications enhance insulin secretion from the pancreas, suppress glucagon release, and slow down gastric emptying, leading to improved glycemic control. Retaglutide is administered orally, while tirzepatide emp